Table 1 Site and Histology types of SPMs after RC that the top 20
Site of SPMs | N | % | Histology of SPMs | N | % |
|---|---|---|---|---|---|
All | 741 | 100.00% | ALL | 741 | 100.00% |
Lung and Bronchus | 136 | 18.35% | Squamous Cell Neoplasms | 158 | 21.32% |
Urinary Bladder | 112 | 15.11% | Adenomas and Adenocarcinomas | 139 | 18.76% |
Rectum | 83 | 11.20% | Transitional Cell Papillomas and Carcinomas | 112 | 15.11% |
Melanoma of the Skin | 63 | 8.50% | Cystic, Mucinous and Serous Neoplasms | 91 | 12.28% |
Sigmoid Colon | 23 | 3.10% | Epithelial Neoplasms, NOS | 67 | 9.04% |
Prostate | 21 | 2.83% | Nevi and Melanomas | 64 | 8.64% |
Soft Tissue including Heart | 18 | 2.43% | Complex Mixed and Stromal Neoplasms | 16 | 2.16% |
Anus, Anal Canal and Anorectum | 18 | 2.43% | Nhl - Mature B-Cell Lymphomas | 14 | 1.89% |
NHL - Extranodal | 15 | 2.02% | Ductal and Lobular Neoplasms | 13 | 1.75% |
Esophagus | 14 | 1.89% | Soft Tissue Tumors and Sarcomas, NOS | 10 | 1.35% |
Stomach | 14 | 1.89% | Complex Epithelial Neoplasms | 8 | 1.08% |
Corpus Uteri | 14 | 1.89% | Fibromatous Neoplasms | 7 | 0.94% |
Tonsil | 13 | 1.75% | Acinar Cell Neoplasms | 7 | 0.94% |
Larynx | 13 | 1.75% | Germ Cell Neoplasms | 6 | 0.81% |
Pancreas | 12 | 1.62% | Oseous and Chondromatous Neoplasms | 3 | 0.40% |
Ascending Colon | 11 | 1.48% | Lipomatous Neoplasms | 3 | 0.40% |
Kidney and Renal Pelvis | 11 | 1.48% | Myomatous Neoplasms | 3 | 0.40% |
Cecum | 11 | 1.48% | Basal Cell Neoplasms | 3 | 0.40% |
Tongue | 9 | 1.21% | Mesothelial Neoplasms | 3 | 0.40% |
Ovary | 9 | 1.21% | Nhl - Mature t and Nk-Cell Lymphomas | 2 | 0.27% |